| HOME >> MEDICINE >> TECHNOLOGY |
- How can companies evaluate which Emerging markets offer the greatest opportunities for their growth?
- What are the expectations for the industry impact of the Chinese government's comprehensive plan for Healthcare reform and expansion?
- Which companies are current industry leaders in terms of Emerging market sales?
Companies mentionedAbbott , Astra Zeneca , Bayer , BMS , Boehringer Ingelheim , Daiichi Sankyo , Eisai , GSK , J&J , Lilly , Merck , Mylan , Novartis , Novo Nordisk , Pfizer , Roche , Sanofi Aventis , Takeda , Teva ,
Table of ContentsOpportunities In Emerging Pharma Markets
Executive summary 10
Overview of emerging markets for pharmaceuticals 10
Emerging market profiles by countries and regions 11
Emerging market growth strategies by leading companies 12
Emerging market opportunities by product segment 13
Recommendations for success in emerging markets 14
Chapter 1 Overview of emerging markets
for pharmaceuticals 16
Summary 16
Introduction 17
Pharmerging countries 18
2007 forecast 18
2008 forecast 19
Multiple classifications of emerging markets 23
China is the largest growth opportunity 25
Emerging market opportunities 26
Emerging market challenges 27
Chapter 2 Emerging market profiles by
country and regions 30
Summary 30
Brazil 32
Market size and forecast 32
Demographics 33
Opportunities and challenges 33
Recent acquisitions and alliances 34
iv
China 34
Market size and forecast 34
Demographics 35
Overview 35
Market segments 36
Opportunity: China's healthcare expansion plan 37
Impact of Chinese healthcare reforms 38
Additional opportunities and challenges 39
China market segmentation: Tier 1, 2 and 3 cities 39
Leading industry com
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |